154 related articles for article (PubMed ID: 38828196)
1. Dual-mRNA Delivery Using Tumor Cell Lysate-Based Multifunctional Nanoparticles as an Efficient Colon Cancer Immunogene Therapy.
Wang K; Gao Y; Wu S; Zhang J; Zhu M; Chen X; Fu X; Duan X; Men K
Int J Nanomedicine; 2024; 19():4779-4801. PubMed ID: 38828196
[TBL] [Abstract][Full Text] [Related]
2. Efficient Colon Cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles.
Huang J; Wang K; Fu X; Zhu M; Chen X; Gao Y; Ma P; Duan X; Men K
Int J Nanomedicine; 2023; 18():8059-8075. PubMed ID: 38164262
[TBL] [Abstract][Full Text] [Related]
3. Single Micelle Vectors based on Lipid/Block Copolymer Compositions as mRNA Formulations for Efficient Cancer Immunogene Therapy.
Li J; Men K; Gao Y; Wu J; Lei S; Yang Y; Pan H
Mol Pharm; 2021 Nov; 18(11):4029-4045. PubMed ID: 34559545
[TBL] [Abstract][Full Text] [Related]
4. Tumor Cell Lysate-Based Multifunctional Nanoparticles Facilitate Enhanced mRNA Delivery and Immune Stimulation for Melanoma Gene Therapy.
Huang J; Wang K; Wu S; Zhang J; Chen X; Lei S; Wu J; Men K; Duan X
Mol Pharm; 2024 Jan; 21(1):267-282. PubMed ID: 38079527
[TBL] [Abstract][Full Text] [Related]
5. Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy.
Gao Y; Men K; Pan C; Li J; Wu J; Chen X; Lei S; Gao X; Duan X
Int J Nanomedicine; 2021; 16():5211-5232. PubMed ID: 34366664
[TBL] [Abstract][Full Text] [Related]
6. Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer.
Liu X; Gao X; Zheng S; Wang B; Li Y; Zhao C; Muftuoglu Y; Chen S; Li Y; Yao H; Sun H; Mao Q; You C; Guo G; Wei Y
Nanomedicine; 2017 Aug; 13(6):1993-2004. PubMed ID: 28428054
[TBL] [Abstract][Full Text] [Related]
7. Treating colon cancer with a suicide gene delivered by self-assembled cationic MPEG-PCL micelles.
Duan X; Wang P; Men K; Gao X; Huang M; Gou M; Chen L; Qian Z; Wei Y
Nanoscale; 2012 Apr; 4(7):2400-7. PubMed ID: 22388488
[TBL] [Abstract][Full Text] [Related]
8. Systemic and Local Administration of a Dual-siRNA Complex Efficiently Inhibits Tumor Growth and Bone Invasion in Oral Squamous Cell Carcinoma.
Ma P; He M; Lian H; Li J; Gao Y; Wu J; Men K; Men Y; Li C
Mol Pharm; 2024 Feb; 21(2):661-676. PubMed ID: 38175819
[TBL] [Abstract][Full Text] [Related]
9. Targeting EZH2 for glioma therapy with a novel nanoparticle-siRNA complex.
Wang X; Hua Y; Xu G; Deng S; Yang D; Gao X
Int J Nanomedicine; 2019; 14():2637-2653. PubMed ID: 31043779
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.
Xu G; Shi H; Ren L; Gou H; Gong D; Gao X; Huang N
Int J Nanomedicine; 2015; 10():2051-63. PubMed ID: 25844036
[TBL] [Abstract][Full Text] [Related]
11. Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1.
Zhou P; Cao Y; Liu X; Yu T; Xu Q; You C; Gao X; Wei Y
Int J Nanomedicine; 2018; 13():4781-4793. PubMed ID: 30214189
[TBL] [Abstract][Full Text] [Related]
12. Local and Systemic Delivery of Interleukin-12 Gene by Cationic Micelles for Cancer Immunogene Therapy.
Men K; Huang R; Zhang X; Zhang R; Zhang Y; He M; Tong R; Yang L; Wei Y; Duan X
J Biomed Nanotechnol; 2018 Oct; 14(10):1719-1730. PubMed ID: 30041719
[TBL] [Abstract][Full Text] [Related]
13. Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system.
Liu X; Li Y; Sun X; Muftuoglu Y; Wang B; Yu T; Hu Y; Ma L; Xiang M; Guo G; You C; Gao X; Wei Y
Theranostics; 2018; 8(13):3490-3503. PubMed ID: 30026861
[No Abstract] [Full Text] [Related]
14. Targeted MIP-3β plasmid nanoparticles induce dendritic cell maturation and inhibit M2 macrophage polarisation to suppress cancer growth.
He Y; Wang M; Li X; Yu T; Gao X
Biomaterials; 2020 Aug; 249():120046. PubMed ID: 32325346
[TBL] [Abstract][Full Text] [Related]
15. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
[TBL] [Abstract][Full Text] [Related]
16. Efficient Colorectal Cancer Gene Therapy with IL-15 mRNA Nanoformulation.
Lei S; Zhang X; Men K; Gao Y; Yang X; Wu S; Duan X; Wei Y; Tong R
Mol Pharm; 2020 Sep; 17(9):3378-3391. PubMed ID: 32787272
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
[TBL] [Abstract][Full Text] [Related]
18. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
[TBL] [Abstract][Full Text] [Related]
19. Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy.
Song W; Tang Z; Lei T; Wen X; Wang G; Zhang D; Deng M; Tang X; Chen X
Nanomedicine; 2016 Feb; 12(2):377-86. PubMed ID: 26711966
[TBL] [Abstract][Full Text] [Related]
20. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery.
Tanaka K; Kanazawa T; Shibata Y; Suda Y; Fukuda T; Takashima Y; Okada H
Int J Pharm; 2010 Aug; 396(1-2):229-38. PubMed ID: 20600726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
